Apple shatters records with $143.8B in Q1 2026 revenue. iPhone 17 demand and a China rebound drive growth, while Tim Cook addresses the Google Gemini AI deal.

If you are wondering whether Regeneron Pharmaceuticals is attractively priced right now, it helps to separate the headlines from what the numbers are actually saying about value. The share price ...

Apple AAPL Q1 2026 earnings call recap: record iPhone and Services growth, AI strategy, and margin outlook amid supply constraints.

Ooops... Something went wrong while loading this page.

Apple reported a big rise in sales to a record $144bn for the final quarter of last year as a surge in iPhone purchases ...

Why Jabil is on investors’ radar today Jabil (JBL) is back in focus after recent share price moves that contrast a slight 1 ...

Apple on Thursday said iPhone sales in the March quarter could be even better than the company's forecast if it could secure enough chips to meet demand.

A blowout holiday quarter and a strong revenue guide for the current March quarter suggest that Apple's strong iPhone cycle will continue.

Apple on Thursday said it saw record-high earnings in the final three months of last year, with iPhone sales surging in ...

New phone designs, coupled with robust holiday spending, continued to lift iPhone sales in the quarter and drove the company ...

Apple today announced financial results for the first fiscal quarter of 2026, which corresponds to the fourth calendar quarter of 2025. For the quarter, Apple posted revenue of $143.8 billion and net ...

Tsai Capital Corporation, an investment management firm, released its fourth quarter 2025 investor letter. A copy of the ...